{"id":151256,"date":"2010-01-07T19:08:42","date_gmt":"2010-01-08T00:08:42","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=57637"},"modified":"2010-01-07T19:08:42","modified_gmt":"2010-01-08T00:08:42","slug":"prometheus-labs-gets-260m-in-debt-financing","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/151256","title":{"rendered":"Prometheus Labs Gets $260M in Debt Financing"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Life-Sciences\/\">Life Sciences<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Financing\/\">Financing<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Drugs\/\">Drugs<\/a><\/div>\n<p>\t\t<strong>Bruce V. Bigelow wrote:<\/strong><\/p>\n<p>San Diego-based Prometheus Laboratories, which develops specialty pharmaceuticals and diagnostic tests, <a href=\"http:\/\/phx.corporate-ir.net\/phoenix.zhtml?c=130685&amp;p=irol-newsArticle&amp;ID=1372178&amp;highlight=\">says today<\/a> it has secured $260 million in financing that consists of a $210 million loan and a $50 million line of credit. The company says proceeds will be used to finance the acquisition of more therapeutic and diagnostic products, and to refinance existing indebtedness.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/01\/07\/prometheus-labs-gets-260m-in-debt-financing\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Prometheus%20Labs%20Gets%20$260M%20in%20Debt%20Financing%20http:\/\/xconomy.com\/?p=57637\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/san-diego\/2010\/01\/07\/prometheus-labs-gets-260m-in-debt-financing\/&#038;t=Prometheus%20Labs%20Gets%20$260M%20in%20Debt%20Financing\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/san-diego\/2010\/01\/07\/prometheus-labs-gets-260m-in-debt-financing\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Prometheus+Labs+Gets+%24260M+in+Debt+Financing&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fsan-diego%2F2010%2F01%2F07%2Fprometheus-labs-gets-260m-in-debt-financing%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=caa49bf66f60d16f49b8907a223cec17&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=caa49bf66f60d16f49b8907a223cec17&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/a.rfihub.com\/eus.gif?eui=2218\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/zO0DGDYXBceMxnPeI1OUYJGmh38\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/zO0DGDYXBceMxnPeI1OUYJGmh38\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/zO0DGDYXBceMxnPeI1OUYJGmh38\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/zO0DGDYXBceMxnPeI1OUYJGmh38\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/Y_kxGHkSY0s\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Life Sciences, Financing, Drugs Bruce V. Bigelow wrote: San Diego-based Prometheus Laboratories, which develops specialty pharmaceuticals and diagnostic tests, says today it has secured $260 million in financing that consists of a $210 million loan and a $50 million line of credit. The company says proceeds will be used to finance the acquisition of more [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-151256","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/151256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=151256"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/151256\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=151256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=151256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=151256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}